Akso Health Group

Akso Health Group

NNASDAQ:AHG
1.33
USD
+0.09
(+7.26%)
-1.47EPS
74.69MMarket Cap
Dec 02Next Earn

Total Valuation

USD

As of September 30, 2019, Akso Health Group carries a market capitalization of 74.69M, placing it among publicly traded companies globally. Its enterprise value stands at 83.35M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap74.69M
Enterprise Value83.35M

Important Dates

Akso Health Group's next confirmed earnings release is scheduled for December 2, 2026.

Earnings Date12/2/2026

Share Statistics

As of September 30, 2019, Akso Health Group has 16.27M shares outstanding.

Shares Outstanding16.27M

Valuation Ratios

These figures are as of September 30, 2019. The price-to-sales ratio is 4.82, and the price-to-book ratio stands at 0.74.

PS Ratio4.82
PB Ratio0.74
P/TBV Ratio0.74

Enterprise Valuation

These figures are as of September 30, 2019. The EV/Sales ratio of 5.37 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 83.35M versus a market cap of 74.69M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales5.37

Financial Position

As of September 30, 2019, Akso Health Group maintains a current ratio of 3.15, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 23.52, indicating elevated leverage, while an interest coverage ratio of -24.77 demonstrates limited ability to service its debt obligations.

Current Ratio3.15
Quick Ratio2.89
Debt / Equity23.52
Debt / EBITDA-0.75
Interest Coverage-24.77

Financial Efficiency

USD

Over the twelve months ended September 30, 2019, Akso Health Group posted a negative return on equity (ROE) of -21.27, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -17.14, reflecting losses generated across the asset base. The company generates approximately 30,193.92 in revenue per employee across its workforce of 514.00, a quick read on workforce productivity versus industry peers.

Return on Equity (ROE)-21.27
Return on Assets (ROA)-17.14
Revenue Per Employee30,193.92
Employee Count514.00

Taxes

USD

Over the twelve months ended September 30, 2019, Akso Health Group recorded an income tax benefit of -4.00M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -28.30M and -24.30M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax-4.00M

Stock Price Statistics

USD

As of the close on November 16, 2026, Akso Health Group's stock has declined approximately 5.67% over the past 52 weeks. The 50-day moving average sits at 1.10, while the 200-day moving average is 1.50.

52-Week Price Change-5.67%
50-Day Moving Average1.10
200-Day Moving Average1.50

Income Statement

USD

Over the twelve months ended September 30, 2019, Akso Health Group generated 15.52M in revenue and converted that into -24.30M in net income, yielding earnings per share of -1.47. EBITDA reached -31.53M, while operating income came in at -30.26M.

Revenue15.52M
Gross Profit7.50M
Operating Income-30.26M
Pretax Income-28.30M
Net Income-24.30M
EBITDA-31.53M
EBIT-31.53M
Earnings Per Share (EPS)-1.47

Balance Sheet

USD

As of September 30, 2019, Akso Health Group holds 14.94M in cash and equivalents against 23.61M in total debt, resulting in a net debt position of 5.76M. Total book value stands at 100.38M, with working capital of 25.88M providing operational flexibility.

Cash & Cash Equivalents14.94M
Total Debt23.61M
Net Debt5.76M
Equity (Book Value)100.38M
Book Value Per Share6.17
Working Capital25.88M

Margins

Over the twelve months ended September 30, 2019, Akso Health Group posted a gross margin of 48.33, reflecting its pricing power and cost economics. The operating margin of -194.97 and net profit margin of -156.60 provide insight into operational efficiency.

Gross Margin48.33
Operating Margin-194.97
Pretax Margin-182.35
Profit Margin-156.60
EBITDA Margin-203.18

Stock Splits

Akso Health Group's most recent stock split took place on August 24, 2020 with a 3:1 split ratio.

Last Split Date8/24/2020
Split Ratio3:1

Scores

As of September 30, 2019, Akso Health Group has an Altman Z-Score of 1.51, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.51